www.eppermed.eu Open in urlscan Pro
212.88.144.91  Public Scan

Form analysis
2 forms found in the DOM

GET https://www.eppermed.eu/

<form role="search" method="get" action="https://www.eppermed.eu/" class="wp-block-search__button-only wp-block-search__searchfield-hidden wp-block-search__icon-button wp-block-search" data-wp-interactive="core/search"
  data-wp-context="{&quot;isSearchInputVisible&quot;:false,&quot;inputId&quot;:&quot;wp-block-search__input-1&quot;,&quot;ariaLabelExpanded&quot;:&quot;Submit Search&quot;,&quot;ariaLabelCollapsed&quot;:&quot;Expand search field&quot;}"
  data-wp-class--wp-block-search__searchfield-hidden="!context.isSearchInputVisible" data-wp-on-async--keydown="actions.handleSearchKeydown" data-wp-on-async--focusout="actions.handleSearchFocusout"><label
    class="wp-block-search__label screen-reader-text" for="wp-block-search__input-1">Search</label>
  <div class="wp-block-search__inside-wrapper " style="width: 100%"><input aria-hidden="true" class="wp-block-search__input has-small-font-size" data-wp-bind--aria-hidden="!context.isSearchInputVisible" data-wp-bind--tabindex="state.tabindex"
      id="wp-block-search__input-1" placeholder="" value="" type="search" name="s" required="" tabindex="-1"><button aria-expanded="false" class="wp-block-search__button has-small-font-size has-icon wp-element-button"
      data-wp-bind--aria-controls="state.ariaControls" data-wp-bind--aria-expanded="context.isSearchInputVisible" data-wp-bind--aria-label="state.ariaLabel" data-wp-bind--type="state.type" data-wp-on--click="actions.openSearchInput"
      aria-controls="wp-block-search__input-1" aria-label="Expand search field" type="button"><svg class="search-icon" viewBox="0 0 24 24" width="24" height="24">
        <path d="M13 5c-3.3 0-6 2.7-6 6 0 1.4.5 2.7 1.3 3.7l-3.8 3.8 1.1 1.1 3.8-3.8c1 .8 2.3 1.3 3.7 1.3 3.3 0 6-2.7 6-6S16.3 5 13 5zm0 10.5c-2.5 0-4.5-2-4.5-4.5s2-4.5 4.5-4.5 4.5 2 4.5 4.5-2 4.5-4.5 4.5z"></path>
      </svg></button></div>
</form>

POST https://secure.pt-dlr.de/pt-newsletter/Newsletter/index/97

<form method="post" action="https://secure.pt-dlr.de/pt-newsletter/Newsletter/index/97" data-endpoint="/wp-json/pt_gutenberg_blocks/v1/newsletter/subscribe"><input type="hidden" name="nlId" value="97">
  <div class="nl-field field-type-text"><input type="hidden" name="newsletter[607]" value=" ">
  </div>
  <div class="nl-field field-type-text"><input type="hidden" name="newsletter[608]" value=" ">
  </div>
  <div class="email-button-wrap">
    <label for="nl-field-2" class="screenreader-only">E-Mail</label>
    <input id="nl-field-2" type="email" name="newsletter[609]" placeholder="E-Mail" required="">
    <button type="submit"><span>Subscribe</span></button>
  </div>
  <div class="checkbox-wrap">
    <label class="custom-checkbox">
      <input id="nl-field-3" type="checkbox"
        name="newsletter[611][I have read the <a href='http://www.increast.eu/en/92.php' title='Link to the privacy policy'> privacy policy</a> and agree to it. Note: Your consent to the use of your personal data can be revoked at any time with effect for the future.]"
        required="" value="checked">
      <span class="checkmark"></span>
      <span> I agree to the storage and handling of my personal data in accordance to the <a href="/data-privacy/">privacy statement</a>. </span>
    </label>
  </div>
</form>

Text Content

COOKIES AND WEBSITE ANALYSIS

We use cookies and the web analytics service Matomo to customize this website to
your needs. Your visit is currently not being tracked.

If you would like to help us, you can choose to allow your visit to be
anonymously counted. Your decision will be stored in a consent cookie that is
automatically deleted after 24 hours. No data is shared with third parties. For
more information, please refer to our data protection. Information about our
service providers can be found in the imprint.

 

Decline Accept

Direkt zum Inhalt Direkt zur Hauptnavigation Direkt zur Suche Direkt zur
Fußleiste
Search

Members Area
 * About EP PerMed
   * Mission & Objectives
   * Partners
   * Governance & Boards
   * International & Regional Activities
 * Get Involved
 * Funding & Projects
   * Open Calls
     * Joint Transnational Call (JTC) 2025
     * Fast Track Call
     * Venture Creator
   * Upcoming Calls
     * Networking Support Call
   * Closed Calls
     * Joint Transnational Call (JTC) 2024
   * Projects & Results
     * Project Database
 * Publications & Resources
   * EP PerMed Publications
     * Strategic Research & Innovation Agenda for Personalised Medicine
     * The Science of You – the EP PerMed Podcast
     * Reports
   * Resources for Researchers
     * Open Access
   * Additional Resources
     * Other PM-related Initiatives & Consortia
     * International Cooperation
 * News & Events
   * News
   * Events
   * Newsletter

 1. Home→
 2. News & Events→
 3. News→
 4. EP PerMed JTC2025 Pre-announcement – Pharmacogenomic Strategies for
    Personalised Medicine (PGxPM2025)


EP PERMED JTC2025 PRE-ANNOUNCEMENT – PHARMACOGENOMIC STRATEGIES FOR PERSONALISED
MEDICINE (PGXPM2025)

November 15, 2024


EP PERMED PRE-ANNOUNCES ITS JTC2025, WHICH IS EXPECTED TO BE LAUNCHED IN
MID-DECEMBER 2024.

© vrx123 – stock.adobe.com

The European Partnership for Personalised Medicine, EP PerMed (supported by the
European Union under Horizon Europe, Grant Agreement N° 101137129), is a
platform for joint programming of national and European regional research and
innovation supporting activities putting into action “The Strategic Research &
Innovation Agenda (SRIA) for Personalised Medicine (2023)” , SRIA for PM (2023),
through dedicated research, development and innovation funding.

EP PerMed funding organisations, listed below, have agreed to launch the joint
transnational call 2025 (JTC2025), co-funded by the EU, to fund multinational
innovative research projects in personalised medicine (PM), which should bring
together academic, clinical/public health and private research teams, thus
enhancing the competitiveness in Europe in this field. The JTC2025 will be
conducted simultaneously by the participating funding organisations in their
respective region/country and coordinated centrally by the Joint Call
Secretariat (JCS), hosted by the German Aerospace Center e.V. – Project
Management Agency, (DLR-PT), Germany.

The call will be implemented in two stages, i.e. a pre- and a full-proposal
phase. The available budget for this call is 35 Mio. € (approx.).

An information day introducing the JTC2025 to the research community will be
organised most probably on January 09, 2025. More details (including the
registration) will follow soon.

DateActionMid of December, 2024Publication of the call09 January 2025JTC2025
information day18 February 2025 (14:00 CET)Deadline for pre-proposal
submissionExpected around 16 May 2025Communication of the results of the
pre-proposal assessment and invitation to the full-proposal stage17 June 2025
(14:00, CEST)Deadline for full-proposal submissionMid/end of August 2025Rebuttal
stageExpected for October 2025Communication of the funding decisions to the
applicantsEnd of 2025, beginning of 2026Expected project start (according to
regional/national funding regulations)

Expected timeline of the call


AIMS OF THE CALL

The overall objectives of the JTC2025 will be to

 * Support research projects in human health on pharmacogenomic strategies for
   personalised medicine approaches that address one or more of the following
   aspects:
   * identification of new pharmacogenomic markers or signatures using
     (multi)-omics data in relation to drug or drug combination.
   * validation of a pharmacogenomic marker or signatures using (multi)-omics
     data in predicting drug or drug combination outcomes.
   * use pharmaco-omics strategies to determine the right dosage, the efficacy
     of treatments and/or the risk of adverse drug response and non-response to
     treatment to tailor personalised treatment pathways, including combined
     treatments (multi-medication).
 * Encourage and enable interdisciplinary collaborations, i.e. multi-actor
   research by engaging a range of other relevant disciplines such as
   pre-clinical and clinical research, bioinformatics/health informatics/data
   research, ELSA research, implementation research or health economics research
   connected to the proposed research topic, including end-user perspective
   analysis to support the implementation of the research outcomes into clinical
   practice.
 * Encourage cross-sectorial collaborations, by including the private sector
   (e.g. SMEs, small and medium-sized enterprises), industry, as well as
   regulatory/HTA agencies and patient organisations.
 * Establish participatory research, i.e. active representation of patients or
   citizens as part of research projects.

Research projects in all disease areas will be welcome.


GENERAL (ELIGIBILITY) CONDITIONS FOR APPLICATION

Whilst applications will be submitted jointly by groups from several countries,
the individual applicants of each group will be funded by the respective
regional/national EP PerMed funding organisation of the individual applicants.
The applications are therefore subject to eligibility criteria and regulations
of individual funding organisations. Applicants are strongly advised to contact
their regional/ national representatives of the participating relevant funding
organisation as soon as possible in order to confirm their eligibility (see also
below “Contact details of participating members”).

Joint research proposals may be submitted by applicants belonging to the
following categories (subject to regional/national funding regulations):

 1. Academia (research teams working in universities, other higher education
    institutions) or research institutes;
 2. Clinical/public health sector (research teams working in hospitals/public
    health and/or other healthcare settings and health organisations).
    Participation of clinicians (e.g. medical doctors, nurses) in the research
    teams is encouraged;
 3. Private for-profit (industry) partners, e.g. SME (small and medium-sized
    enterprises) and private non-profit partners, e.g. foundations, associations
    or non-governmental organisations.

More information about the eligibility criteria and rules regarding consortium
composition will be available soon.


PARTNERING TOOL

A new partnering tool developed and supported by the EP PerMed will be available
for the call.


PARTICIPATING COUNTRIES AND EUROPEAN REGIONS

The following countries (23) are participating in the preparation of the call:
Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, France, Germany,
Greece, Hungary, Iceland, Ireland, Israel, Italy, Latvia, Lithuania, Luxembourg,
Norway, Poland, Portugal, Spain, Sweden and Turkiye (contact list is provided
below).

Besides national funders, the following regions are participating (10): Flanders
(Belgium), Wallonia-Brussels Federation (Belgium), Saxony (Germany), Lombardy
(Italy), Tuscany (Italy), Azores (Portugal), Centro Region (Portugal), Andalusia
(Spain), Catalonia (Spain) and Navarre (Spain).

*decision on participation is still pending

Please note:

The information provided in this pre-announcement is indicative and may be
subject to changes and is not legally binding to funding organisations.
Additional funding organisations might join the call before the official
publication or leave the funders consortium.

Interested applicants are encouraged to initiate scientific contacts with
potential project consortium partners for applications. The final call
information is expected to be published on the EP PerMed website in December
2024.


LIST OF REGIONAL/NATIONAL CONTACTS

Name of participating organisationCountry/RegionRegional/National
contactAustrian Science Fund, (FWF)AustriaHannes Zwickl
hannes.zwickl@fwf.ac.at
Tel.: +43 676 83487 8219The Research Foundation – Flanders, (FWO)Belgium
(Flanders)Toon Monbaliu (FO)
Kristien Peeters (SBO) europe@fwo.be
Tel.: +32 (0)2 550 15 70
Tel.: +32 (0)2 550 15 95Fund for Scientific Research – FNRS,
(F.R.S.-FNRS)Belgium (Wallonia-Brussels Federation)Maxime Bonsir
international@frs-fnrs.be
Tel.: +32 2504 9236The Ministry of Health of the Czech Republic / Czech Health
Research Council, (MZCR/AZVCR)Czech RepublicMonika Kocmanova
Monika.kocmanova@azvcr.cz
Tel.: +420 606 273 871Innovation Fund Denmark, (IFD)DenmarkKatrine Boeriis
katrine.boeriis@innofond.dk
internationale@innofond.dk
Tel.: +45 61 90 50 06Estonian Ministry of Social Affairs, (MoSAE)EstoniaMari
Teesalu
Mari.teesalu@sm.ee
Tel.: +372 5916 2047Estonian Research Council, (ETAG)EstoniaMargit Suuroja
Margit.Suuroja@etag.ee
Tel.: +372 731 7360
Argo Soon
Argo.Soon@etag.ee
Tel.: +372 515 3424Business Finland, (BFRK)FinlandNorma Jäppinen
norma.jappinen@businessfinland.fi
Matti Hiltunen
matti.hiltunen@businessfinland.fi
Tel.: +358 50 5577 012
Tel.: +358 50 5577 652Agence Nationale de la Recherche, (ANR)FranceMonika
Frenzel
Tel: (+33) (0) 1 73 54 83 32
EPPerMed@agencerecherche.frFederal Ministry of Education and
Research, (BMBF)
German Aerospace Center e.V. – Project Management Agency, (DLR)GermanyUte Preuss
Jacqueline Kalb
permed@dlr.de
Tel.: +49 228 3821-2211Federal Ministry of Health, (BMG) German Aerospace Center
e.V. – Project Management Agency, (DLR)GermanyComing soonSaxon State Ministry
for Science, Culture and Tourism, (SMWK)Germany (Saxony)Coming soonGeneral
Secretariat for Research & innovation, (GRST)Greece Coming soonNational
Research, Development and Innovation Office, (NKFIH)HungaryZsuzsanna Kürti
nemzetkozi@nkfih.gov.hu
zsuzsanna.kurti@nkfih.gov.hu
Tel.: +36 70 375 0036The Icelandic Centre for Research, (RANNIS)IcelandHelga
Snævarr Kristjánsdóttir
Helga.s.kristjansdottir@rannis.isResearch Ireland, (RI)IrelandEmma McGrath
Emma.mcgrath@researchireland.ie
eu-Cofund@sfi.ie
Tel.: +353 86 1991351Chief Scientist Office, Ministry of Health,
(CSO-MOH)IsraelLiron Even-Faitelson
Liron.ef@moh.gov.il
Tel.: +972-2-5082168Italian Ministry of Health, (IT-MoH)ItalyMaria Josefina Ruiz
Alvarez
mj.ruizalvarez-esterno@sanita.it
Tel.: (+39) 06-4990 6836
Chiara Ciccarelli
c.ciccarelli@sanita.it
Tel.: (+39) 06-5994 3919Fondazione Regionale per la Ricerca Biomedica,
(FRRB)Italy (Lombardy)Giulia Maria Rossignolo
bandi@frrb.it
Tel.: +39 0267650159Tuscany Region, (RT)Italy (Tuscany)Donatella Tanini
Teresa Vieri
eppermed@regione.toscana.it
Tel.: +39 055 4383256
Tel.: +39 055 4383289Latvian Council of Science, (LZP)LatviaUldis Berkis
Uldis.Berkis@lzp.gov.lv
Tel.: +37129472349Research Council of Lithuania, (LMT)LithuaniaŽivilė Ruželė
zivile.ruzele@lmt.lt
Tel.: (+370) 676 14383Luxembourg National Research Fund (FNR)LuxembourgGideon
Gießelmann
gideon.giesselmann@fnr.lu
Tel.: +352 691 362 805The Research Council of Norway, (RCN)NorwayKatrine Rolid
karo@rcn.no
Tel.: +47 415 48 328National Centre for Research and Development,
(NCBR)PolandAnna Stępień
anna.stepien@ncbr.gov.pl
Tel.: +48 22 39 07 210Fundação para a Ciência e a Tecnologia, (FCT)PortugalRita
Cavaleiro
Pedro Ferreira
EPPerMed@fct.pt
Tel.: +351 213 911 541
Tel.: +351 213 924 445Vice-Presidency of Azores Regional Government,
(VP-GRA)Portugal (Azores)Maria Vale
Tel.: +351 296 308 922
Maria.LA.Vale@azores.gov.ptComissão de Coordenação e Desenvolvimento Regional do
Centro, (CCDRC)Portugal (Centro Region)Sophie Patrício
Dora Cabete ccdrc.projects@ccdrc.pt
Tel.: +351 239400127National Institute of Health Carlos III, (ISCIII)SpainMaría
Callejo Arranz
mcallejo@isciii.es
Tel.: +34918222503Consejería de Salud y Consumo de la Junta de Andalucía,
(CSCJA)Spain (Andalusia)Alicia Milano Curto
ep.fps@juntadeandalucia.esHealth Department – Generalitat de Catalunya,
(DS-CAT)Spain (Catalonia)Montserrat Llavayol
peris@gencat.cat
Tel.: +34 935566103Government of Navarre, (CFN)Spain (Navarre)Javier Rodrigo
Javier.rodrigo.aznarez@navarra.es
Tel.: +34 848 42 76 69Sweden´s Innovation Agency, (VINNOVA)*SwedenMalin Eklund
Malin.eklund@Vinnova.se
Tel.: +46 730 20 39 53
Casper Ullsten-Wahlund
casper.ullsten-wahlund@vinnova.se
Tel.: +46 730 20 51 25The Scientific and Technological Research Council of
Turkey, (TUBITAK)TurkiyeN. Selcan TÜRKER
selcan.turker@tubitak.gov.tr
Tel.: +90 312 298 1760

List of National Contacts

* Final decision for participation is still pending.

Download Pre-anouncement (PDF)



Back to all news

EP PerMed has received funding from the European Union’s Horizon Europe research
and innovation programme under grant agreement No 101137129.

DLR Projektträger Division Health Innovations for Disease Control
Heinrich-Konen-Str. 1 53277 Bonn Germany

+49 228 3821-1144 e-mail: eppermed@dlr.de
www.DLR-PT.de

Imprint

Data Privacy

Accessibility Statement

 * About EP PerMed
   * Mission & Objectives
   * Partners
   * Governance & Boards
   * International & Regional Activities
 * Get Involved
 * Funding & Projects
   * Open Calls
     * Joint Transnational Call (JTC) 2025
     * Fast Track Call
     * Venture Creator
   * Upcoming Calls
     * Networking Support Call
   * Closed Calls
     * Joint Transnational Call (JTC) 2024
   * Projects & Results
     * Project Database
 * Publications & Resources
   * EP PerMed Publications
     * Strategic Research & Innovation Agenda for Personalised Medicine
     * The Science of You – the EP PerMed Podcast
     * Reports
   * Resources for Researchers
     * Open Access
   * Additional Resources
     * Other PM-related Initiatives & Consortia
     * International Cooperation
 * News & Events
   * News
   * Events
   * Newsletter

NEWSLETTER

E-Mail Subscribe
I agree to the storage and handling of my personal data in accordance to the
privacy statement.

Welcome!

You have successfully subscribed to the EP PerMed newsletter. Please confirm
your registration by clicking on the link you have recieved via email.

Whoops!

Something went wrong. Please try again.




Find us on: